ChromaDex Corporation

ChromaDex Corporation is a bioscience company that focuses on healthy aging. The company operates through three segments: Consumer products, Ingredients, and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+) and provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors. ChromaDex also develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. Its flagship ingredient NIAGEN, a NAD+ precursor nicotinamide riboside, is an active ingredient in its consumer products under the TRU NIAGEN name. In addition, IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, is used to support human immune function. The company also offers analytical reference standards and services to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries.

ChromaDex distributes its TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. Its products are also available in several countries around the world, including the United Kingdom, Canada, Australia, and New Zealand. The company has also established partnerships with several leading companies in the nutrition and health industries, such as Thorne Research, NOW Foods, and GNC, to expand the availability of its products. ChromaDex Corporation is headquartered in Los Angeles, California and has been in business since 1999. It is a publicly traded company on the NASDAQ exchange and has a market capitalization of over $400 million.